NCT03393494View on ClinicalTrials.gov

Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

PHASE3CompletedINTERVENTIONAL
Enrollment

825

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

January 5, 2019

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene and Benzoyl Peroxide Topical Gel

Test product

DRUG

Epiduo Topical Product

RLD product

DRUG

Placebo

Placebo gel

Trial Locations (1)

27262

Dermatology Consultants, High Point

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT03393494 - Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face | Biotech Hunter | Biotech Hunter